Aug. 14 at 6:14 PM
$ITRM
The buck stops with the payor. With uUTI, you’re ruining women’s gut microbiomes with repeated use of the generics- interesting science coming out on the gut microbiome & disease link.
if all the 26 million resistant uUTI cases were given Orly at the first office visit- so instead of a
$5 drug, insurers now cover a
$2500 drug- you guys do the math re cost for insurers- that’s why with the AMR narrative, the one group that has to pay for all of this(payors) is quiet.
Everyone loves the story , but the group picking up the bill re uUTI, isn’t saying much. As my husband has explained, you don’t have 💩until you have a CPT code and reimbursement. The reason prior auth is even there to begin with ISN’T bec. payors doubt it works- it’s because of cost. That’s why cUTI is the real value➡️ you need 18-24 months + $$$.
With cUTIs you’ll see payors championing Orly: “It’s so important! We love Orly”
Reality: they cut hospital stay IN HALF- huge $ saver for payors.
400-700 Mil BO target.
